BINTAI

0.075

-0.005 (-6.2%)

VARIATION IN THE TERMS OF THE SHARE SALE AGREEMENT DATED 28 APRIL 2021 BETWEEN BINTAI AND YEO ENG LAM ON THE ACQUISITION OF JOHNSON MEDICAL INTERNATIONAL SDN BHD

Amended Announcements
Please refer to the earlier announcement reference number: GA1-19122022-00016

BINTAI KINDEN CORPORATION BERHAD

Type Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID IQL-16122022-00001
Subject VARIATION IN THE TERMS OF THE SHARE SALE AGREEMENT DATED 28 APRIL 2021 BETWEEN BINTAI AND YEO ENG LAM ON THE ACQUISITION OF JOHNSON MEDICAL INTERNATIONAL SDN BHD
Description
BINTAi KINDEN CORPORATION BERHAD
Variation in the terms of the Share Sale Agreement dated 28 April 2021 between the Company and Yeo Eng Lam for the acquisition of Johnson Medical International Sdn Bhd
Query Letter Contents

We refer to BINTAI’s announcement dated 14 December 2022 in respect of the aforesaid matter.
 

In this connection, kindly furnish Bursa Securities with the following additional information for public release:

  1. The salient terms and conditions of the respective New Agreements.
  2. The relationship between Rinani Care Sdn. Bhd. (“RCSB”) and Madam Yeo Eng Lam (“YEL”).
  3. The rationale and justification to novate YEL’s obligations for the Profit Guarantee to RCSB.
  4. The details and clarification in respect to the obligations to fulfil the Receivables Guarantee pursuant to the Share Sale Agreement dated 28 April 2021 in view that YEL has been discharged from her obligation for the Profit Guarantee.
  5. Whether the variation tantamount to a Material Variation pursuant to Paragraph 8.22 of the Main Market Listing Requirements which require shareholders’ approval, together with the basis and justification.

Please furnish Bursa Securities with your reply within one (1) market day from the date hereof.

 

Yours faithfully

 

 

Listing

Regulation

 

cc: Market Surveillance Dept.  Securities Commission (via fax)

We refer to the the announcement made by the Company dated 19 December 2022 and for avoidance of doubt, the Board of Directors of BINTAI wishes to announce that in response to  item 5 of Bursa Malaysia Securities Berhad's query letter, the Company will be seeking its shareholders’ approval in regards to the proposed material variation in the terms of the Share Sale Agreement dated 28 April 2021 entered into between the Company and Yeo Eng Lam for the Acquisition of Johnson Medical International Sdn Bhd pursuant to Paragraph 8.22 of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad.

 

The draft Circular to Shareholders in relation thereto shall be sent to Bursa Malaysia Securities Berhad for review prior to the issuance to the shareholders in due course, within the stipulated timeframe in accordance with the Main Market Listing Requirements of Bursa Securities.

 

This announcement is dated 20 December 2022.





Announcement Info

Company Name BINTAI KINDEN CORPORATION BERHAD
Stock Name BINTAI
Date Announced 20 Dec 2022
Category General Announcement for PLC
Reference Number GA1-20122022-00065